Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction-Reference-Cited by-同舟云学术

Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction

Published:2019-11-13 Issue:1 Volume:53 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif

Author:

Liu Lin¹,Wang Fan¹,Tong Yu¹,Li Lin‐Feng¹,Liu Yanfeng¹,Gao Wei‐Qiang¹²^ORCID

Affiliation:

1. State Key Laboratory of Oncogenes and Related Genes Renji‐Med‐X Clinical Stem Cell Research Center Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

2. School of Biomedical Engineering & Med‐X Research Institute Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.12718

Reference53 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Prostate cancer

3. Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

4. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

5. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding mechanism of pentamidine derivatives with human serum acute phase protein α1-acid glycoprotein;International Journal of Biological Macromolecules;2024-05

2. The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and risk of prostate cancer;International Urology and Nephrology;2024-01-27

3. Uncovering impaired mitochondrial and lysosomal function in adipose-derived stem cells from obese individuals with altered biological activity;Stem Cell Research & Therapy;2024-01-08

4. Mitochondrial DNA-targeted therapy: A novel approach to combat cancer;Cell Insight;2023-08

5. Toxoplasma gondii infection: novel emerging therapeutic targets;Expert Opinion on Therapeutic Targets;2023-05-04